Lei Xun, Huang Ke, Liu Qin, Jie Yong-Feng, Tang Sheng-Lan
China Effective Health Care Network, Research Center for Medicine and Social Development, Innovation Center for Social Risk Governance in Health, School of Public Health and Management, Chongqing Medical University, Chongqing, China.
Public Health Clinical Center of Chengdu, Chengdu, China.
Infect Dis Poverty. 2016 May 5;5:38. doi: 10.1186/s40249-016-0134-9.
Tuberculosis (TB) patients face numerous difficulties adhering to the long-term, rigorous TB treatment regimen. Findings on TB patients' treatment adherence vary across existing literature and official reports. The present study attempted to determine the actual treatment adherence of new TB patients and to identify factors leading to non-adherence.
A prospective cohort of 481 newly confirmed TB patients from three counties in western China were enrolled during June to December 2012 and was followed until June 2013. Patients who missed at least one dose of drugs or one follow-up re-examination during the treatment course were deemed as non-adherent. Influencing factors were identified using a logistic regression model.
A total of 173 (36.0 %) patients experienced non-adherence and the loss to follow-up cases reached 136 (28.2 %). Only 13.9 % of patients took drugs under direct observation, and 60.5 % of patients were supervised by phone calls. Factor analyses suggested that patients who were observed by family members (OR:5.54, 95 % CI:2.87-10.69) and paying monthly service expenses above 450 RMB (OR:2.08, 95 % CI:1.35-3.19) were more likely to be non-adherent, while supervision by home visit (OR:0.06, 95 % CI:0.01-0.28) and phone calls (OR:0.27, 95 % CI:0.17-0.44) were protective factors.
Despite recent efforts, a large proportion of newly confirmed TB patients could not adhere to standard TB treatment, and patients' lost to follow-up was still a serious problem. Poor treatment supervision and heavy financial burden might be the main causes for non-adherence. More needs to be done to enhance treatment supervision policies and financial supports to both health providers and TB patients.
结核病患者在坚持长期、严格的结核病治疗方案方面面临诸多困难。现有文献和官方报告中关于结核病患者治疗依从性的研究结果各不相同。本研究旨在确定新确诊结核病患者的实际治疗依从性,并找出导致不依从的因素。
2012年6月至12月,在中国西部三个县招募了481名新确诊的结核病患者组成前瞻性队列,并随访至2013年6月。在治疗过程中至少漏服一剂药物或错过一次随访复查的患者被视为不依从。使用逻辑回归模型确定影响因素。
共有173名(36.0%)患者出现不依从情况,失访病例达136名(28.2%)。只有13.9%的患者在直接观察下服药,60.5%的患者通过电话接受督导。因素分析表明,由家庭成员观察的患者(比值比:5.54,95%置信区间:2.87 - 10.69)和每月服务费用超过450元人民币的患者(比值比:2.08,95%置信区间:1.35 - 3.19)更有可能不依从,而家访督导(比值比:0.06,95%置信区间:0.01 - 0.28)和电话督导(比值比:0.27,95%置信区间:0.17 - 0.44)是保护因素。
尽管最近做出了努力,但仍有很大比例的新确诊结核病患者无法坚持标准的结核病治疗,患者失访仍是一个严重问题。治疗督导不力和沉重的经济负担可能是不依从的主要原因。需要采取更多措施加强对医疗服务提供者和结核病患者的治疗督导政策及财政支持。